NEUPERT PETER M

SEC Form 4 insider
Adaptive Biotechnologies Corp ($ADPT)
1 thesis · first seen Aug 20, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d111100%-0.2%-0.2%
3d1100%+2.0%+2.0%
1w1100%+2.6%+2.6%
1m1100%+12.2%+12.2%
3m1100%+11.8%+11.8%
6m000———
1y000———

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$ADPTSEC Form 4bearish
Sold 124,690 @ $25.15 avg · $3,135,850 · 2026-08-17

Form 4: NEUPERT PETER M sold ADPT

NEUPERT PETER M (Director at Adaptive Biotechnologies Corp) reported an open-market sale of 124,690 shares of ADPT at an average $25.15, roughly $3,135,850, in a Form 4 filed 2026-08-19.

At post $25.49Now $28.46+11.7% since posted3m ago
1d-0.2%
3d+2.0%
1w+2.6%
1m+12.2%
3m+11.8%
6m—
1y—
View filing on SEC.gov →

End of results.